The Protein Engineering Market is Predict to reach USD 7.8 Billion by 2031, at a CAGR of 16.0%

Protein Engineering Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Protein Engineering Market size is expected to reach $7.8 billion by 2031, rising at a market growth of 16.0% CAGR during the forecast period.

The Instruments segment is generating the highest revenue in the Global Protein Engineering Market by Product in 2023; thereby, achieving a market value of $3.8 billion by 2031. This can be attributed to the high demand for sophisticated protein engineering research and development instruments, such as chromatography, mass spectrometers, and protein crystallization systems.

The Pharmaceutical & Biotechnology Companies segment is registering a CAGR of 15.5 % during the forecast period. This is due to the fact that the pharmaceutical and biotechnology industries have a significant demand for protein engineering technologies for the purposes of drug discovery, development, and production.

The Rational Protein Design segment led the Global Protein Engineering Market by Technology in 2023; thereby, achieving a market value of $2 billion by 2031. Rational protein design uses computational methods to predict and modify protein structures for specific functions or properties. This approach is favored for its precision and efficiency in protein engineering, leading to its widespread adoption in drug discovery, enzyme engineering, and other biotechnological applications.

The Monoclonal Antibodies segment is growing at a CAGR of 13.6 % during the forecast period. A revolutionary development has been the application of monoclonal antibodies to the treatment of autoimmune disorders and cancer. They are designed to bind specifically to antigens on cancer cells or immune cells, thereby marking them for destruction by the body's immune system or blocking harmful processes.

Full Report: https://www.kbvresearch.com/protein-engineering-market/

The North America region dominated the Global Protein Engineering Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3 billion by 2031. The Europe region is anticipated to grow at a CAGR of 15.6% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 16.7% during (2024 - 2031).

List of Key Companies Profiled

• Agilent Technologies, Inc.
• Bruker Corporation
• Thermo Fisher Scientific, Inc.
• Waters Corporation
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Danaher Corporation
• Genscript Biotech Corporation
• Amgen, Inc.
• Promega Corporation

Protein Engineering Market Report Segmentation

By Product

• Instruments
• Reagents
• Software & Services

By End-use

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic Research Institutes

By Technology

• Rational Protein Design
• Hybrid Approach
• Directed Evolution
• De Novo Protein Design
• Others

By Protein Type

• Monoclonal Antibodies
• Insulin
• Vaccines
• Growth Factors
• Interferon
• Colony Stimulating Factors
• Coagulation Factors
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Protein Engineering Market Size Report - 2031

• June-2024
• 131 Pages

LAMEA Protein Engineering Market Size & Analysis | 2031

• June-2024
• 146 Pages

Europe Protein Engineering Market Size & Forecast | 2031

• June-2024
• 148 Pages

Asia Pacific Protein Engineering Market Size Report - 2031

• June-2024
• 148 Pages